SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-002738
Filing Date
2018-09-14
Accepted
2018-09-14 07:47:21
Documents
37
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cannapharmarx_10q-033117.htm 10-Q 183282
2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 cannapharmarx_10q-ex3101.htm EX-31.1 8528
3 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 cannapharmarx_10q-ex3102.htm EX-31.2 8037
4 CERTIFICATION cannapharmarx_10q-ex32.htm EX-32 4335
  Complete submission text file 0001683168-18-002738.txt   1004818

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20170331.xml EX-101.INS 107910
6 XBRL SCHEMA FILE cpmd-20170331.xsd EX-101.SCH 12664
7 XBRL CALCULATION FILE cpmd-20170331_cal.xml EX-101.CAL 24125
8 XBRL DEFINITION FILE cpmd-20170331_def.xml EX-101.DEF 17948
9 XBRL LABEL FILE cpmd-20170331_lab.xml EX-101.LAB 91659
10 XBRL PRESENTATION FILE cpmd-20170331_pre.xml EX-101.PRE 72679
Mailing Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614
Business Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 181070075
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1